Cover Image

QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular age‐related macular degeneration

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Samantha Arokiasamy, Michaela J. M. Balderstone, Faheem Shaik, Enrico Cristante, Thomas C. Moseley, Akshay Madoo, Matteo Rizzi, James W. Bainbridge, Konstantin Tsoyi, Ivan O. Rosas, James R. Whiteford, Giulia De Rossi
Format:	Artículo Open Access
Published:	Wiley 2024
Subjects:	British Journal of Pharmacology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Recurrence after treat‐and‐extend suspension in neovascular age‐related macular degeneration: A real‐world analysis by macular neovascularization subtype
by: Geoffrey Zeender, et al.
Published: (2026)

Case series: Brolucizumab efficacy and safety in treating neovascular age‐related macular degeneration
by: Linling Cheng, et al.
Published: (2025)

Reactivation of stable neovascular age‐related macular degeneration following treat‐and‐extend regimen discontinuation
by: Jose Carlo M. Artiaga, et al.
Published: (2024)

Impact of delayed appointments on treatment outcomes in neovascular macular degeneration
by: Petri Purola, et al.
Published: (2026)

Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration
by: Imadeddin Abu Ishkheidem, et al.
Published: (2025)

Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age‐related macular degeneration
by: Scott Lenhof, et al.
Published: (2024)

Impact of diabetes and diabetic retinopathy on neovascular exudative age‐related macular degeneration
by: Pasquale Viggiano, et al.
Published: (2025)

The impact of neovascular age‐related macular degeneration on driving from a patient perspective
by: Benjamin Sommer Thinggaard, et al.
Published: (2025)

Injection burden and treatment intervals of aflibercept in observe‐and‐plan regimen for neovascular age‐related macular degeneration
by: Yousif Subhi, et al.
Published: (2024)

Monomeric C‐reactive protein exacerbates choroidal neovascularization in vivo: Implications for age‐related macular degeneration
by: Patricia Fernandez‐Robredo, et al.
Published: (2024)

Lower bounds for $\text{GL}_2(\mathbb{F}_\ell)$ number fields
by: Cristante, Vittoria
Published: (2024)

Incidence of choroidal neovascularisation in the fellow eye in neovascular age‐related macular degeneration patients and its correlation with type of drusen
by: Tina Xirou, et al.
Published: (2024)

Prechoroidal cleft in neovascular age‐related macular degeneration ( AMD) : A narrative review of pathophysiology, clinical implications and prognosis
by: Clara Rizzo, et al.
Published: (2026)

Characterizing and assessing vision‐related quality of life among patients discontinued treatment for neovascular age‐related macular degeneration
by: Noreddin Shekho, et al.
Published: (2025)

To the Editors:
by: Perianayagam Arokiasamy
Published: (2014)

Real‐world experience with brolucizumab in pro re nata regimen in patients with neovascular age‐related macular degeneration previously treated with ranibizumab and aflibercept and without control of subretinal fluid
by: Salvatore Di Lauro, et al.
Published: (2024)

Hyperreflective material boundary remodelling: A new morphological biomarker of good functional outcomes in neovascular age‐related macular degeneration
by: Siqing Yu, et al.
Published: (2024)

Genetics in neovascular age‐related macular degeneration susceptibility and treatment response to anti‐VEGF intravitreal injection: A case series study
by: Fang‐Yu Chang, et al.
Published: (2024)

Comparative efficacy of intravitreal anti‐VEGF therapy for neovascular age‐related macular degeneration: A systematic review with network meta‐analysis
by: Emilie T. S. Butler, et al.
Published: (2025)

Retinal imaging biomarkers in assessing treatment response when switching from aflibercept to faricimab in resistant neovascular age‐related macular degeneration cases
by: Stamatina Kabanarou, et al.
Published: (2025)

Beyond drug price: A comparison of overall costs of anti‐vascular endothelial growth factor therapy alternatives for neovascular age‐related macular degeneration in Norway
by: Jacopo F. T. Løkken, et al.
Published: (2026)

Comparison of AI‐based retinal fluid monitoring in neovascular age‐related macular degeneration with manual assessment by different eye care professionals under optimized conditions
by: Martin Michl, et al.
Published: (2025)

General Reference Tools, Subject Reference Tools in Science and Technology.
by: Moseley, James L.
Published: (1982)

Three Models for Individualizing Instruction in Library Education.
by: Moseley, James L.
Published: (1982)

Biomarkers in age‐related macular degeneration
by: Chandrakumar Balaratnasingam, et al.
Published: (2024)

Up to 10‐month outcomes of faricimab in treating treatment‐refractory wet age‐related macular degeneration
by: Nicole Tay, et al.
Published: (2025)

The long‐term impact of neovascular age‐related macular degeneration undergoing routine treatment in first and second eyes on vision‐related quality‐of‐life: FASBAT Report 3
by: Archana Airody, et al.
Published: (2026)

Bevacizumab en el tratamiento de la degeneración macular neovascular asociada a la edad
by: A. Monzón Moreno
Published: (2006)

Distrofia macular viteliforme de Best asociada a membrana neovascular coroidea en edad pediátrica
by: Sara Berdugo-Mesa
Published: (2019)

Nocturnal hypoxia and age‐related macular degeneration
by: Attiqa Chaudhary, et al.
Published: (2024)

Diagnostic accuracy of OCT angiography for macular neovascularization in central serous chorioretinopathy: A systematic review and meta‐analysis
by: Hans Christian Kiilgaard, et al.
Published: (2024)

Neovascular age‐related macular degeneration without drusen
by: Marc J. Sirks, et al.
Published: (2025)

Gut microbial dysbiosis in age‐related macular degeneration
by: Joëlle Vergroesen, et al.
Published: (2025)

Gut microbial dysbiosis in age‐related macular degeneration
by: Joëlle Vergroesen, et al.
Published: (2025)

The New Corporate Governance in Theory and Practice
by: Bainbridge, Stephen
Published: (2026)

Victorian Women and the Gendering of Mountaineering in the Alps
by: William Bainbridge
Published: (2025)

How To Use the Card Catalog: A Study Booklet. Developed for Use in the Juvenile Section of a Community Library.
by: Krzeczkowski, Angela, et al.
Published: (1993)

Letter to the editor: The photochromatic interval in age‐related macular degeneration
by: Harold E. Bedell
Published: (2025)

Age‐related macular degeneration discordance in monozygotic twin pairs
by: Fabian Kananen, et al.
Published: (2024)

Current updates for hyperuricemia and gout in age‐related macular degeneration
by: Hung‐Liang Pai, et al.
Published: (2024)